NCT00002036View on ClinicalTrials.gov

Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Anti-HIV Immune Serum Globulin (Human)

Trial Locations (1)

55455

Univ of Minnesota, Minneapolis

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY